Base-pair resolution DNA methylome of the EBV-positive Endemic Burkitt lymphoma cell line DAUDI determined by SOLiD bisulfite-sequencing

Leukemia

Volumn 27, Issue 8, 2013, Pages 1751-1753

  Kreck, B ^a   Richter, J ^a   Ammerpohl, O ^a   Barann, M ^a   Esser, D ^a   Petersen, B S ^a   Vater, I ^a   Murga Penas, E M ^a   Bormann Chung, C A ^b   Seisenberger, S ^c   Lee Boyd, V ^b   Smallwood, S ^c   Drexler, H G ^d   MacLeod, R A F ^d   Hummel, M ^e   Krueger, F ^c   Hasler R ^a   Schreiber, S ^a,f   Rosenstiel, P ^a   Franke, A ^a   Siebert, R ^a   more..

^a UNIVERSITY OF KIEL   (Germany)

^b Life Technologies Corporation   (United States)

^c BABRAHAM INSTITUTE   (United Kingdom)

^d Babraham Institute ^*  (Germany)

^e CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^f UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BISULFITE; DNA; DNA FRAGMENT; GENOMIC DNA; IMMUNOGLOBULIN; MYC PROTEIN;

ADOLESCENT; B CELL LYMPHOMA; BASE PAIRING; BURKITT LYMPHOMA; CASE REPORT; CPG ISLAND; DAUDI CELL; DNA METHYLATION; EMBRYONIC STEM CELL; EMULSION; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; EXOME; GENE EXPRESSION; GENE MUTATION; HUMAN; KARYOTYPE; KARYOTYPING; LETTER; LYMPHOMA CELL LINE; MALE; ONCOGENE MYC; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PYROSEQUENCING; SINGLE NUCLEOTIDE POLYMORPHISM;

BURKITT LYMPHOMA; CELL LINE, TUMOR; DNA METHYLATION; EXOME; GENE EXPRESSION REGULATION, NEOPLASTIC; HERPESVIRUS 4, HUMAN; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; KARYOTYPING; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84881479943     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2013.4     Document Type: Letter

References (23)

1. Manolov G, Manolova Y. Marker band in one chromosome 14 from Burkitt lymphomas. Nature 1972; 237: 33-34.
2. Zech L, Haglund U, Nilsson K, Klein G. Characteristic chromosomal abnormalities in biopsies and lymphoid-cell lines from patients with Burkitt and non-Burkitt lymphomas. Int J Cancer 1976; 17: 47-56.
3. Salaverria I, Siebert R. The gray zone between Burkitt's lymphoma and diffuse large B-cell lymphoma from a genetics perspective. J Clin Oncol 2011; 29: 1835-1843.
4. Boerma EG, Siebert R, Kluin PM, Baudis M. Translocations involving 8q24 in Burkitt lymphoma and other malignant lymphomas: a historical review of cytogenetics in the light of todays knowledge. Leukemia 2009; 23: 225-234.
5. Richter J, Schlesner M, Hoffmann S, Kreuz M, Leich E, Burkhardt B et al. Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing. Nat Genet 2012 2012; 44: 1316-1320.
6. Love C, Sun Z, Jima D, Li G, Zhang J, Miles R et al. The genetic landscape of mutations in Burkitt lymphoma. Nat Genet 2012 2012; 44: 1321-1325.
7. Schmitz R, Young RM, Ceribelli M, Jhavar S, Xiao W, Zhang M et al. Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics. Nature 2012 2012; 490: 116-20.
8. Martín-Subero JI, Kreuz M, Bibikova M, Bentink S, Ammerpohl O, Wickham-Garcia E et al. New insights into the biology and origin of mature aggressive B-cell lymphomas by combined epigenomic, genomic, and transcriptional profiling. Blood 2009; 113: 2488-2497.
9. Shaknovich R, Geng H, Johnson NA, Tsikitas L, Cerchietti L, Greally JM et al. DNA methylation signatures define molecular subtypes of diffuse large B-cell lymphoma. Blood 2010; 116: e81-e89.
10. Shaknovich R, Cerchietti L, Tsikitas L, Kormaksson M, De S, Figueroa ME et al. DNA methyltransferase 1 and DNA methylation patterning contribute to germinal center B-cell differentiation. Blood 2011; 118: 3559-3569.
11. Lister R, Pelizzola M, Dowen RH, Hawkins RD, Hon G, Tonti-Filippini J et al. Human DNA methylomes at base resolution show widespread epigenomic differences. Nature 2009; 462: 315-322.
12. Klein E, Klein G, Nadkarni JS, Nadkarni JJ, Wigzell H, Clifford P. Surface IgM-kappa specificity on a Burkitt lymphoma cell in vivo and in derived culture lines. Cancer Res 1968; 28: 1300-1310.
13. Nadkarni JS, Nadkarni JJ, Clifford P, Manolov G, Fenyö EM, Klein E. Characteristics of new cell lines derived from Burkitt lymphomas. Cancer 1969; 23: 64-79.
14. Sander S, Calado DP, Srinivasan L, Köchert K, Zhang B, Rosolowski M et al. Synergy between PI3K signaling and MYC in Burkitt lymphomagenesis. Cancer Cell 2012; 22: 167-179.
15. Krueger F, Kreck B, Franke A, Andrews SR. DNA methylome analysis using short bisulfite sequencing data. Nat Methods 2012; 9: 145-151.
16. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006; 126: 663-676. (Pubitemid 44233629)
17. Hummel M, Bentink S, Berger H, Klapper W, Wessendorf S, Barth TF et al. A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling. N Engl J Med 2006; 354: 2419-2430. (Pubitemid 43855045)
18. Li Y, Zhu J, Tian G, Li N, Li Q, Ye M et al. The DNA methylome of human peripheral blood mononuclear cells. PLoS Biol 2010; 8: e1000533.
19. Lin Z, Xu G, Deng N, Taylor C, Zhu D, Flemington EK. Quantitative and qualitative RNA-Seq-based evaluation of Epstein-Barr virus transcription in type I latency Burkitt's lymphoma cells. J Virol 2010; 84: 13053-13058.
20. Flower K, Thomas D, Heather J, Ramasubramanyan S, Jones S, Sinclair AJ. Epi-genetic control of viral life-cycle by a DNA-methylation dependent transcription factor. PloS ONE 2011; 6: e25922.
21. Dresang LR, Teuton JR, Feng H, Jacobs JM, Camp 2nd DG, Purvine SO et al. Coupled transcriptome and proteome analysis of human lymphotropic tumor viruses: insights on the detection and discovery of viral genes. BMC Genomics 2011; 12: 625.
22. Leenman EE, Panzer-Grü mayer RE, Fischer S, Leitch HA, Horsman DE, Lion T et al. Rapid determination of Epstein-Barr virus latent or lytic infection in single human cells using in situ hybridization. Mod Pathol 2004; 17: 1564-1572. (Pubitemid 39627084)
23. Kim DN, Song YJ, Lee SK. The role of promoter methylation in Epstein-Barr virus (EBV) microRNA expression in EBV-infected B cell lines. Exp Mol Med 2011; 43: 401-410.